BW-00112

N/A

Report date: 2025/04/03 14:48:41
NME

Base Information

Drug NameBW-00112
Drug Alias NameBW-00112BW00112
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionAngiopoietin like 3 modulators
TargetsAngiopoietin like 3
Therapy Area/IndicationsHypertriglyceridemiaDyslipidemias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShanghai Argo Biopharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShanghai Argo Biopharmaceutical Co LtdHangzhou Bolin Pharmaceutical Technology Co LtdNovartis Pharma Ag
Inactive CompaniesN/A
Active IndicationsHypertriglyceridemiaDyslipidemias
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A